Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00739336 · ClinicalTrials.gov registry record · NA

Diabetes Prevention and Control in the Workplace: A Pilot Study

A NA study of Type 2 Diabetes Mellitus, sponsored by State University of New York - Upstate Medical University.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT00739336 is a NA study of Type 2 Diabetes Mellitus that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 45 participants, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00739336, a NA study of Type 2 Diabetes Mellitus, has completed, sponsored by State University of New York - Upstate Medical University.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

This worksite program for Onondaga County employees is a pilot research study aimed at decreasing the risk of developing diabetes (or improving metabolic control for adults with diabetes). The main goal is to improve the nutrition and physical habits of the participants, and promote weight loss in those who are overweight. The investigators will also examine factors that predict participation in the program and influence a participant's outcome/success in the program.

Conditions Studied

Interventions

  • BEHAVIORAL Diabetes Prevention and Control

Study Locations (1)

New York

  • SUNY Upstate Medical University - Syracuse

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2008-07
Est. Completion 2014-12
Phase NA

What the Registry Record Tells You About NCT00739336

The ClinicalTrials.gov registry entry for NCT00739336 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (98% lower). The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Diabetes Prevention and Control is the first listed.

NCT00739336 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00739336 about?

NCT00739336 is a clinical study titled "Diabetes Prevention and Control in the Workplace: A Pilot Study". This worksite program for Onondaga County employees is a pilot research study aimed at decreasing the risk of developing diabetes (or improving metabolic control for adults with diabetes). The main goal is to improve the nutrition and physical habits of the participants, and promote weight loss in t...

What is the current status of trial NCT00739336?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2008-07. Estimated completion is 2014-12.

What conditions does trial NCT00739336 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT00739336?

The interventions under investigation include: Diabetes Prevention and Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT00739336?

This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00739336 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.